Skip to content

A Study for Metabolomics based TCM Syndrome Classification of Idiopathic Pulmonary Fibrosis

A Study for Metabolomics based TCM Syndrome Classification of Idiopathic Pulmonary Fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018757
Enrollment
Unknown
Registered
2018-10-08
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

Control group:Nil
Case group:Nil

Sponsors

Xuzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Case group inclusion criteria 1. According to the diagnostic criteria published in 2015, the New Guidelines for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis, jointly developed by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Society; 2. aged 50 to 85 years old; Control group inclusion criteria: Health people match on the age (±3 years old) and gender with case group with 1:1 rate at the same time.

Exclusion criteria

Exclusion criteria: Case group exclusion criteria: 1. Those with severe heart, liver, kidney and other organ dysfunction or suffering from blood diseases; 2. with malignant tumors; 3. Severely infected people; 4. Pregnant and lactating women; 5.mental illness, serious obstacles and those who are unwilling to cooperate; Control group exclusion criteria: 1. Those with severe heart, liver, kidney and other organ dysfunction or blood disease; 2. With malignant tumors; 3. Chest X-ray or chest low-dose CT suggesting intra-pulmonary interstitial fibrosis; 4. With chronic pulmonary diseases such as pulmonary interstitial disease, chronic obstructive pulmonary disease, and bronchial asthma; 5. With connective tissue disease and those with a history of exposure to occupational diseases; 6. Mental illness, serious obstacles and unwilling to cooperate.

Design outcomes

Primary

MeasureTime frame
Metabolomics;

Secondary

MeasureTime frame
Pulmonary function;Six Minute Walk Test;

Countries

China

Contacts

Public ContactYING ZHAO

Xuzhou traditional Chinese Medicine Hospital

njmuzy@126.com+86 18205211881

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026